Guardant Health Inc
Diagnostics & Research
Healthcare
GH
124 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
59.95
52 week high
67.42
high
61.68
52 week low
0.00
low
59.37
growth
138.02 %
previous Close
59.78
P/E ratio
market cap
7.08 B
div yield
0
usd
Jun 2025
qoq
revenue
232 M
14.06 %
net incoming
-99.90 M
-4.98 %
eps
0.00 %
10.20 %
eps surprise
38.89 %
net profit margin
-43.04 %
3.00 %
operating incoming
-106.41 M
4.17 %
net change in cash
-68.37 M
-139.27 %
cash on hand
629 M
-9.94 %
cost of revenue
81.21 M
8.67 %
top top